Press Releases
EU approves Alprolix (rFIXFc) for the Treatment of Haemophilia...
First Fc Fusion Therapy Approved for haemophilia B in the EU to Provide Extended Protection Against Bleeds Swedish Orphan Biovitrum AB and...
Press Releases
AbbVie Inc to participate at the UBS Global Health...
AbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill Chase, executive vice president and chief financial officer, will participate...
Press Releases
Mylan Launches Generic Frova Tablets for for migraine headaches...
Mylan N.V. announced the U.S. launch of Frovatriptan Succinate Tablets 2.5 mg, a generic version of Endo's Frova® Tablets. Mylan received final approval from the...
Press Releases
Pfizer awards more than $1 million to fund metastatic...
Pfizer Inc announced that it has awarded a total of more than $1 million in funding to five leading breast cancer advocacy organizations to support...
Press Releases
Johnson & Johnson opens first international JLABs site in...
Johnson & Johnson Innovation LLC announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices,...
Press Releases
Merck Expands Popular Line of Guava® Flow Cytometers
Optical configurations meet needs of any lab, research discipline or individual application Product can detect up to 14 parameters from a single sample ...
Press Releases
Empliciti (elotuzumab) for the Treatment of Multiple myeloma treatment...
First and only immunostimulatory antibody approved in the European Union for multiple myeloma Accelerated assessment and approval based on long-term data from ELOQUENT-2,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.